Talzenna (Talazoparib) Capsules is used to treat locally advanced or metastatic HER2-negative breast cancer with an inherited BRCA1 or BRCA2 mutation.

TALZENNA is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) HER2-negative locally advanced or metastatic breast cancer. Select patients for therapy based on an FDA-approved companion diagnostic for TALZENNA.

Talzenna (Talazoparib) Capsules suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Talzenna (Talazoparib) Capsules brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Talzenna (Talazoparib) Capsules medicine cost price in India.

The order for Talzenna (Talazoparib) Capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Talazoparib (trade name Talzenna) is an orally available poly ADP ribose polymerase (PARP) inhibitor developed by Pfizer for the treatment of advanced breast cancer with germline BRCA mutations. Talazoparib is similar to the first in class PARP inhibitor, olaparib. It was approved in 2018 in the United States and 2019 in Europe for germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer.

  • Talazoparib is used to treat HER2-negative breast cancer that has spread to other parts of the body. Talazoparib is used only if your cancer has a specific genetic marker (an abnormal "BRCA" gene). Your doctor will test you for this gene. Talazoparib may also be used for purposes not listed in this medication guide.
  • Talzenna (Talazoparib) Capsules for oral administration Initial U.S. Approval: 2018

    Generic Name: Talazoparib

    Talzenna (Talazoparib) Capsules Price in UK Brazil India

    Talzenna (Talazoparib) Capsules Capsules, for oral use is available.

    Get In Touch

    Indian Pharma Network (IPN), Delhi. India

    IPN, Delhi is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient, providing solutions on how to get access of anti cancer medicines which is not available in India.

    BRANCH OFFICE : NEW DELHI | BENGALURU | KOLKATA | LUCKNOW | JODHPUR

    Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

    Indian Pharma Network

    60/4 1st Floor, T&T Building, Indian Oil Complex,
    Yusuf Sarai, New Delhi, Delhi 110016

    Mobile / WhatsApp / Phone

    M: +91 9811747774, 9891296838.
    P: +91-11-26532129 / 26536398

    Free Customer Support

    info@indianpharmanetwork.co.in
    urgent@indianpharmanetwork.co.in

    Talzenna (Talazoparib) Capsules suppliers in India

    IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand pemnat (Pemetrexed) Capsules on prescription and Import License in Patient's Name only.

    For overseas patients, pemnat (Pemetrexed) Capsules can be made available in Send your enquiry to find pemnat (Pemetrexed) Capsules in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for Talzenna (Talazoparib).

    For Talzenna (Talazoparib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

    Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update. For More Details

    FDA Approves Generic Talazoparib Capsules